.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Prof. Dr. Christine Goffinet

Berlin / DE

Charité – Universitätsmedizin Berlin

Speaker

30/03/2023
09:15 – 09:30 12 Min. 3 Min.
Abstract Talk
O 082
Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism
Antiviral therapy and resistance, Host cell factors and modulation

Further involvements

28/03/2023
Poster
P 040
Combining latency-reversing agents with type I IFNs accumulates HIV-1 Env on the cell surface and sensitizes for the elimination of HIV-reactivating cells through antibody-dependent cellular cytotoxicity
Antiviral therapy and resistance, Viral pathogenesis and persistence
28/03/2023
Poster
P 119
MPOX virus infects human PBMCs in a type I interferon-sensitive manner
Emerging viruses and zoonosis, Host cell factors and modulation
28/03/2023
Poster
P 211
Characterization of extracellular vesicles from various body fluids that show broad antiviral activities
Host cell factors and modulation, Innate immunity
28/03/2023
Poster
P 338
SARS-CoV-2 exposure facilitates LRA-mediated reactivation of HIV-1 in latently infected monocytes
Host cell factors and modulation, Viral pathogenesis and persistence
28/03/2023
Poster
P 246
SARS-CoV-2 cell-to-cell transmission, as opposed to cell-free infection, evades from cell-intrinsic innate and humoral immunity
Innate immunity, SARS-CoV-2
28/03/2023
18:45 – 19:00 12 Min. 3 Min.
Abstract Talk
O 029
A novel role for ISG15 in restricting acute and persistent HIV-1 infection
Innate immunity, Viral pathogenesis and persistence
30/03/2023
09:15 – 09:30 12 Min. 3 Min.
Abstract Talk
O 082
Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism
Antiviral therapy and resistance, Host cell factors and modulation
31/03/2023
11:45 – 12:00 12 Min. 3 Min.
Abstract Talk
O 107
A novel, high dimensional model of latent HIV-1 infection and latency reversal cure strategies
Antiviral therapy and resistance, Viral pathogenesis and persistence